Healthcare
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 23, 2025 → Jun 18, 2026
Coverage: 249 bars · Jun 23, 2025 → Jun 18, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
TransGlobal Assets Inc. (TMSH) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Jun 18, 2026). Baseline metrics include revenue growth of -100.0%, EPS growth of +300.0%, a dividend yield of 0.0%. What stands out right now is revenue -100.0%, EPS +300.0%, free cash flow -620.1% with operating margin 0.0% and ROIC -44.1%. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines TMSH price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TMSH
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TMSH Max Drawdown
-75.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TMSH and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$515.9K
-42.6% YoY
Free Cash Flow
-$2.1M
-833.6% YoY
Revenue Growth
-100.0%
EPS Growth
+300.0%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 167K | 213K | 0 | 0 |
| Gross Profit | 0 | 87K | 171K | 0 | 0 |
| Operating Income | -638K | -93K | 1K | -292K | -403K |
| EBITDA | -638K | -13K | 1K | -292K | -403K |
| Net Income | -786K | -208K | -110K | -362K | -516K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 250 | 4K | 17K | 10K | 24K |
| Total Assets | 1M | 3M | 3M | 1M | 3M |
| Total Liabilities | 2M | 2M | 2M | 1M | 3M |
| Shareholder Equity | -659K | 1M | 1M | -83K | 181K |
| Total Debt | 2M | 1M | 1M | 1M | 3M |
| Net Debt | 2M | 1M | 1M | 1M | 2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
352K
-59.1% YoY
Capital Expenditures
2M
Free Cash Flow
2M
-833.6% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
101.4%
Debt / Equity
-2.44x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.